Assessment of hepatic oxidative damage, paraoxonase-1 activity, and lipid profile in cattle naturally infected with Babesia bigemina

Esmaeilnejad, Bijan; Dalir‐Naghadeh, Bahram; Tavassoli, Mousa; Asri‐Rezaei, Siamak; Mahmoudi, Soraya; Rajabi, Sepideh; Aligolzadeh, Armin; Akbarī, Ḥamīd; Morvaridi, Asghar

doi:10.1007/s11250-021-02662-x

Cited by 6 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It has been reported that imidocarb is used in the treatment and can be observed in the winter of the disease (Şahal et al, 2009). It has been reported that administration of imidocarb, oxytetracycline and vitamins to 20 cattle naturally infected with Babesia bigemina did not cure all patients and some died (Esmaeilnejad et al, 2021).…”

Section: Cattlementioning

confidence: 99%

Imidocarb Use in Animals

Uslu

Canbar

2022

Veteriner Farmakoloji Ve Toksikoloji Derneği Bülteni

View full text Add to dashboard Cite

Imidocarb dipropionate is a carbanilide derivative antiprotozoan drug. The drug is approved for use in animals for the treatment of tick-borne transmitted babesiosis (piroplasmosis) and anaplasmosis. However, its effectiveness against some other microorganisms transmitted by ticks has also been investigated. Although cattle, horses, donkeys, mules, dogs and sheep are defined as target species, they can also be used in other domestic and wild animals. Although it is recommended to use the drug as a single dose, it can be applied 2-3 days later if necessary. The therapeutic index of the drug is narrow, and attention should be paid to the dosage regimen. In this review, it could be tried to give information about the use of imidocarb in animal species, its success in treatment and its side effects.

show abstract

Section: Cattlementioning

confidence: 99%